All ATC classes · L01E

L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors L4

Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源：维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源：維基百科 · CC BY-SA 4.0 · 回退名 (en)

ATC level L4 · Search this class · Consumer categories

Active ingredients in this class

5 active ingredients 5 principios activos 5 个活性成分 5 個有效成分

Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.

A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.

An ATC class only groups medicines by similar pharmacology/chemistry — it does not mean they are interchangeable. A different ingredient, dosage form, release mechanism or strength is not interchangeable.

Only ingredients with a recorded ATC class are listed (6,009 of 12,637).

Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.